Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Zhejiang Hisun Pharmaceutical Co, Ltd. (600267 CH)
Watchlist
27
Analysis
Health Care
•
China
Zhejiang Hisun Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical products. The Company's products include anti-tumor, anti-parasite, cardiovascular, and anti-infection drugs.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
04 Aug 2016 16:39
Critique of Genome Scientific Work
China’s state media reported this week that Han Chunyu’s scientific results on genome editing which were published in Nature Biotechnology in May...
Bixmoor
Follow
232 Views
Share
bearish
•
Thematic (Sector/Industry)
•
04 Aug 2016 16:05
China's Disconnect on Illegal Drugs
Senior Chinese officials regularly make all the appropriate noises about the evils of illicit drug use in China, but they seem unable to do...
Bixmoor
Follow
620 Views
Share
bullish
•
Thematic (Sector/Industry)
•
26 Feb 2016 05:38
Coming to the HKEX Soon....................
Bloomberg has published a story (that others have cited) that WuXi Pharmatech has picked bankers for an HK listing of its biologics manufacturing...
Kemp Dolliver, CFA
225 Views
Share
bullish
•
Thematic (Sector/Industry)
•
18 Feb 2016 23:01
Time to Go Shopping for Healthcare
The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...
Kemp Dolliver, CFA
250 Views
Share
bullish
•
Thematic (Sector/Industry)
•
09 Jul 2015 06:01
Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder
China Nepstar's Chairman and his China Neptunus Drugstore Holding Ltd. (54% owner) has offered $2.60/ADS to take the company private (announcement...
Kemp Dolliver, CFA
365 Views
Share
First
Previous
2
3
4
5
6
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.0
x